Skip to main content
Government Contracting

GAO Finds Mixed Cost Impacts from Vertically Integrated Medicare PBMs

A new Government Accountability Office report reveals that vertically integrated Medicare Part D plan sponsors directed nearly 28% of pharmacy payments to their own mail-order dispensaries in 2023, yielding lower generic drug costs but higher beneficiary expenses for select high-cost specialty medications.

October 6, 2026·2 min read·Updated November 20, 2026·Analysis·By Defense Signals Desk·Sourced intelligence·
Signal Intelligence™ · generating Executive Brief

A newly released Government Accountability Office (GAO) report highlights the expanding influence of vertical integration across federal prescription drug coverage. Analyzing 2023 data from four major Medicare Part D plan sponsors—representing over 40 percent of total enrollment—GAO found that owned pharmacies captured approximately 24 percent of drug utilization and 28 percent of total pharmacy payments. These vertically integrated entities, which combine health plan sponsors, pharmacy benefit managers (PBMs), and pharmacy networks under common ownership, predominantly leveraged mail-order distribution models compared to non-owned retail providers.

The report underscores a complex pricing dynamic created by internal healthcare supply chains. For the 100 most common prescription drugs—primarily low-cost generics—payments and beneficiary cost-sharing were lower at owned pharmacies for at least 94 percent of medications. However, for high-cost, brand-name drugs, vertical integration did not consistently reduce expenses. For roughly half of the 20 highest-payment drugs per 30-day supply, beneficiary cost-sharing at owned pharmacies was up to $340 higher than at independent retail options, raising questions about patient steering and cross-subsidization strategies within consolidated PBM structures.

Signal Pro feature

This signal is in the subscriber archive.

Signals older than seven days are reserved for members. Subscribe to read the full analysis and unlock the complete Defense Signals archive.

Executive takeaway

Get signals like this in your inbox every morning — the Executive Brief™, complimentary.

See all plans